Rethinking surgical site infection in children with asthma: the role of frailty screening
Published
September 15, 2025
Paper ID
PAP-000166
Status
Published
DOI
10.65712/tmj.test000424
Advance Services
Abstract
Background: surgical site infection remains a leading cause of avoidable harm among children with asthma. Methods: Missing data were handled with multiple imputation. Results: surgical site infection occurred in 16% of the intervention group versus 24% of controls. Effects were consistent across prespecified subgroups. Conclusion: Implementation will depend on staffing, cost and local protocols.
Introduction
Practice around frailty screening varies widely between centres. The cost of surgical site infection to health systems is substantial.
The cost of surgical site infection to health systems is substantial. Earlier studies of frailty screening were small or single-centre.
Discussion
Future work should test frailty screening in a pragmatic multicentre trial. These findings suggest that frailty screening is associated with better surgical site infection in children with asthma.
Future work should test frailty screening in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
Residual confounding cannot be excluded. These findings suggest that frailty screening is associated with better surgical site infection in children with asthma. Future work should test frailty screening in a pragmatic multicentre trial.
Implementation will depend on staffing, cost and local protocols. These findings suggest that frailty screening is associated with better surgical site infection in children with asthma. Strengths include the sample size and blinded outcome assessment.
Conclusions
Frailty screening may be offered for children with asthma to improve surgical site infection.
References
1. Nasser S, Lindqvist C, et al. Early enteral nutrition and patient satisfaction. Ann Intern Med. 2014;178(8):279-1159.
2. Dubois M, Ibrahim F, et al. Early enteral nutrition and emergency department revisits. Eur Heart J. 2015;59(5):450-1548.
3. Rahman J, Herrera Y, et al. Machine-learning triage and medication adherence. BMC Med. 2024;70(11):462-1568.
4. Moreau W, Herrera M, et al. Low-dose aspirin and medication adherence. Diabetes Care. 2022;329(3):772-1088.
5. Ahmed S, Mensah I, et al. Machine-learning triage and medication adherence. JAMA. 2018;83(8):315-1355.
6. Kim K, Lindqvist G, et al. Frailty screening and length of stay. BMC Med. 2017;355(3):405-926.
7. Herrera V, Okafor U, et al. An antibiotic stewardship programme and acute kidney injury. Eur Heart J. 2013;261(12):303-1504.
8. Moreau Z, Osei S, et al. A sepsis alert system and emergency department revisits. Lancet. 2019;165(5):691-1611.
Appendices
The statistical analysis plan is in the online supplement.
Materials and Methods
Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.
We conducted a cross-sectional survey across 10 centres between 2016 and 2025. Missing data were handled with multiple imputation. We conducted a cross-sectional survey across 9 centres between 2016 and 2025. Eligible participants were children with asthma.
We conducted a cross-sectional survey across 12 centres between 2015 and 2022. Analyses were adjusted for age, sex and baseline severity. The primary outcome was surgical site infection, assessed blind to allocation. We conducted a cross-sectional survey across 6 centres between 2014 and 2022.
Results
surgical site infection occurred in 16% of the intervention group versus 22% of controls. Effects were consistent across prespecified subgroups.
Serious adverse events were rare and similar between groups. surgical site infection occurred in 22% of the intervention group versus 18% of controls. surgical site infection occurred in 13% of the intervention group versus 21% of controls.
| Group | n | Events | Rate % | OR |
|---|---|---|---|---|
| Control | 457 | 66 | 13.4 | 0.83 |
| Centre B | 366 | 2 | 6.1 | 0.41 |
| Intervention | 54 | 38 | 21.3 | 0.66 |
| Control | 570 | 69 | 12.5 | 0.68 |
| Female | 848 | 68 | 9.2 | 0.90 |
Values are n (%) unless stated otherwise.

Shown for children with asthma; error bars are 95% confidence intervals.

Shown for children with asthma; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.50 (95% CI 0.50 to 0.86).